Skip to main content

Table 1 Delineation of “high-risk” patients by the respective variables and scores

From: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial

  1. The percentages of patients identified as being of high risk (first column) and the overlap of the respective groups of patients are shown
  2. GPI, gene expression-based proliferation index; (r)ISS, (revised) International Staging System
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us